Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-333543
Filing Date
2013-08-14
Accepted
2013-08-14 06:06:32
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d566311d10q.htm 10-Q 654572
2 EX-10.4 d566311dex104.htm EX-10.4 495701
3 EX-10.5 d566311dex105.htm EX-10.5 47482
4 EX-31.1 d566311dex311.htm EX-31.1 6578
5 EX-31.2 d566311dex312.htm EX-31.2 6512
6 EX-32.1 d566311dex321.htm EX-32.1 4144
13 GRAPHIC g566311ex10_4pg085.jpg GRAPHIC 13738
  Complete submission text file 0001193125-13-333543.txt   6967663

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alxa-20130630.xml EX-101.INS 590661
8 XBRL TAXONOMY EXTENSION SCHEMA alxa-20130630.xsd EX-101.SCH 42596
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20130630_cal.xml EX-101.CAL 49477
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20130630_def.xml EX-101.DEF 137204
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20130630_lab.xml EX-101.LAB 345949
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20130630_pre.xml EX-101.PRE 240586
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 131034804
SIC: 2834 Pharmaceutical Preparations